Evercore ISI Group Maintains Outperform on CVS Health, Lowers Price Target to $62
Portfolio Pulse from Benzinga Newsdesk
Evercore ISI Group analyst Elizabeth Anderson maintains an Outperform rating on CVS Health but lowers the price target from $65 to $62.
August 08, 2024 | 1:04 pm
News sentiment analysis
Sort by:
Ascending
NEUTRAL IMPACT
Evercore ISI Group analyst Elizabeth Anderson maintains an Outperform rating on CVS Health but lowers the price target from $65 to $62.
The Outperform rating suggests a positive outlook for CVS Health, but the lowered price target indicates some caution. This mixed signal is likely to result in a neutral short-term impact on the stock price.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 100